Dr. Scott Kamelle is a trailblazer in the field of gynecologic oncology, recognized for his holistic and comprehensive approach to cancer care. While early detection and effective treatment are undoubtedly crucial, Dr. Scott Kamelle understands that the journey for women diagnosed with gynecologic cancers—such as ovarian, uterine, and cervical cancers—extends far beyond the diagnosis. His commitment to compassionate, patient-centered care addresses not only the physical aspects of cancer but also the emotional, psychological, and social challenges that women face throughout their treatment and recovery. One of the central tenets of Dr. Kamelle’s comprehensive care model is his focus on personalized...

Healthcare systems are constantly striving to balance two competing priorities—making essential medicines more affordable while fostering innovation for groundbreaking treatments. This intricate balancing act has grown increasingly complex in recent years, as escalating drug prices ignite debates on equity and access in healthcare. To tackle these challenges, the pharmaceutical industry leverages Health Economics and Outcomes Research (HEOR) as a powerful tool. HEOR provides data-backed insights that help streamline healthcare expenditures while keeping innovation within the reach of stakeholders. This blog explores how pharma heorhelps achieve the delicate equilibrium between drug affordability and pharmaceutical innovation in a rapidly expanding global healthcare...